Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)-pyrazole derivatives

被引:112
作者
Chimenti, F
Maccioni, E
Secci, D
Bolasco, A
Chimenti, P
Granese, A
Befani, O
Turini, P
Alcaro, S
Ortuso, F
Cirilli, R
La Torre, F
Cardia, MC
Distinto, S
机构
[1] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Sostanze Biologicament, I-00185 Rome, Italy
[2] Univ Roma La Sapienza, CNR, Ctr Biol Mol, I-00185 Rome, Italy
[3] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy
[4] Univ Catanzaro Magna Graecia, Dipartimento Sci Farmaco Biol Complesso Nini Barb, I-88021 Roccelletta Di Borgia, CZ, Italy
[5] Ist Super Sanita, Lab Chim Farmaco, I-00161 Rome, Italy
[6] Univ Cagliari, Dipartimento Farmaco Chim Tecnol, I-09124 Cagliari, Italy
关键词
D O I
10.1021/jm040903t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)-pyrazole derivatives have been synthesized and investigated for the ability to inhibit selectively the activity of the A and B isoforms of monoamine oxidase (MAO). All the synthesized compounds show high activity against both the MAO-A and the MAO-B isoforms with K-i values between 27 and 4 nM and between 50 and 1.5 nM, respectively, except for a few derivatives whose inhibitory activity against MAO-B was in the micromolar range. Knowing that stereochemistry may be an important modulator of biological activity, we performed the semipreparative chromatographic enantioseparation of the most potent, selective, and chiral compounds. The separated enantiomers were then submitted to in vitro biological evaluation. The selectivity of the (S)-1 enantiomer against MAO-B increases twice and a half, while the selectivity of the (S)-4 enantiomer against XIAO-A triples. Both the MAO-A and MAO-B isoforms respectively of the 105W and 1GOS models deposited in the Protein Data Bank were considered in the computational study. The docking study was carried out using several computational approaches with the aim of proposing possible binding modes of the MAO enantioselective compounds 1 and 4.
引用
收藏
页码:7113 / 7122
页数:10
相关论文
共 48 条
[1]  
Abell CW, 2001, PROG NUCLEIC ACID RE, V65, P129
[2]  
Alcaro S, 2000, J COMPUT CHEM, V21, P515, DOI 10.1002/(SICI)1096-987X(200005)21:7<515::AID-JCC2>3.0.CO
[3]  
2-5
[4]  
Amrein R, 1999, Adv Neurol, V80, P509
[5]   CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES [J].
BACH, AWJ ;
LAN, NC ;
JOHNSON, DL ;
ABELL, CW ;
BEMBENEK, ME ;
KWAN, SW ;
SEEBURG, PH ;
SHIH, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4934-4938
[6]  
Basford R. E., 1967, METHOD ENZYMOL, V10, P96
[7]  
Berendsen H. J. C., 1981, Intermolecular Forces, P331, DOI [10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]
[8]   GROMACS - A MESSAGE-PASSING PARALLEL MOLECULAR-DYNAMICS IMPLEMENTATION [J].
BERENDSEN, HJC ;
VANDERSPOEL, D ;
VANDRUNEN, R .
COMPUTER PHYSICS COMMUNICATIONS, 1995, 91 (1-3) :43-56
[9]  
BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3584
[10]   Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders [J].
Binda, C ;
Newton-Vinson, P ;
Hubálek, F ;
Edmondson, DE ;
Mattevi, A .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (01) :22-26